Kalaris Therapeutics names Liisa Bayko as CFO
Go back to Kalaris Therapeutics names Liisa Bayko as CFO| (NASDAQ: KLRS) | Delayed: 3.62 -0.3 (7.65%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.92 | 52 Week High | $ | |||
| Open | $3.87 | 52 Week Low | $ | |||
| Day High | $3.97 | P/E | N/A | |||
| Day Low | $3.52 | EPS | $ | |||
| Volume | 77,373 | |||||

